Texas strong

The show must go on with these SXSW-related events in Houston and Austin

SXSW was canceled this year due to the rising threat of COVID19, aka the coronavirus, but these events are still ones to check out if you are still planning on attending. Marie Ketring/via sxsw.org

With SXSW canceled — and now the Houston Livestock Show and Rodeo has followed suit — and Austin and Houston entrepreneurs are reeling from the loss of networking, pitch competitions, and business opportunities. But unaffiliated organizations are trying to keep some of the spirit of SXSW alive in both Texas cities and online.

"Coronavirus dropped an economic bomb on Austin, and we are trying to triage the scraps," says Marc Nathan, vice president of client strategy at Egan Nelson, an Austin-based, startup-focused law firm.

The economic impact of SXSW 2019 was reported by the organization to have been over $350 million, and, even assuming this year's festival was on par with that, the city of Austin has lost more than that — from the affect on restaurants, lodging, and more. At this point, refunds are not being given out to badge holders.

Additionally, the organization itself is hurting. The 10-day festival has a year-round staff of over 150 people, and SXSW has recently laid off around 30 percent of those employees. Nathan, who says he highly suspects the organization will have to look into restructuring or even bankruptcy, also notes the cancelation will hurt individuals in a way that's not so easy to track.

"This did affect individuals," Nathan says. "Yes, the big brands were hurt and lost a lot of money, but it's not about them. It's about the little guys — the startups that wanted to launch, the bands that wanted to play, or the films that were selected for the contest. It's all the people who use SXSW as a platform, and that platform just disintegrated."

A group of scrappy Austinites have banded together to create Rally Austin and are putting together resources and events online for those still coming into the city and are looking to network responsibly. A few events are also taking place digitally. Here's a list of events to attend, and keep an eye on Rally Austin for any last-minute updates.

Houston-based WatchHerWork's Female Founders Day (March 12 in Austin)

Two Houston female founders — Reda Hicks and Denise Hamilton — saw an opportunity to make SXSW more female friendly, and that's what they've done by introducing this new unofficial SXSW event. Click here for more.

Hicks recently joined the Houston Innovators Podcast to discuss the opportunity. Click here to listen.

SoFin @ SXSW 2020 (March 13 in Austin)

Focused on fintech solutions, SoFin will go on as planned and will feature Houston-based iownit.us, a blockchain-enabled investment platform. Click here for more info.

The Austin Tech Happy Hour will also still be held on Friday, March 13, in Austin. Click here for more info.

Houston-based Hatch Pitch Competition (March 16 hosted online)

The annual pitch competition, which is usually streamed online, will switch to completely online only. Click here for more info.

Hatch Pitch is also expected to host a Houston-based, cybersecurity-focused competition next month. Click here to read more.

OpenCoffee Club (March 16 in Austin)

Open Coffee Club, a monthly networking opportunity, will continue as planned. Networking is encouraged, handshaking is not. Click here for more info.

Digital Pitch - An Alternative to SXSW2020 (March 17 hosted online)

Houston's Startup Grind has organized a digital pitch competition that will be hosted completely online. Click here for more info.

Startup of the Year Virtual Pitch Competition (March 17 hosted online)

The Established's annual pitch competition is going online, despite The Established House's physical location being canceled. A Houston-based company will still pitch and the competition has Houston judges involved as well. Click here for more info.

Trending News

Building Houston

 
 

This month, TMCi is welcoming a slew of health tech and cancer innovators who will advance solutions in medicine over the next several months. Image via TMC.edu

The Texas Medical Center has announced the latest cohorts of its two health tech accelerators.

The Texas Medical Center Innovation has named eight companies that are in the Spring 2023 Accelerator for HealthTech cohort. TMCi also announced 21 participants are set to join the 2023 Accelerator for Cancer Therapeutics cohort. Both programs connect the entrepreneurs and innovators to experts at TMC’s campuses to solve unmet clinical needs and reach the next business milestone.

“At TMC Innovation, we start with a promise of uniting cutting-edge innovators in science and medicine with the talent found at the Texas Medical Center," says Emily Reiser, associate director of TMC Innovation, in a news release. "Our 2023 cohort members are tackling some of the most critical issues we face today in healthcare.

"We are excited to welcome a new group of researchers and companies to the TMC Innovation Factory, and to work collaboratively with our new cohort members and our partners from across the Texas Medical Center," she continues.

Here's what 2023 can expect from these two program's cohorts.

TMCi HealthTech Accelerator

The six-month, twice annual HealthTech Accelerator — originally launched in 2014 with over 225 alumni companies — focuses on digital health and medical device startups. The spring cohort are addressing solutions across maternal medicine, mental health, diagnostics, patient experience, and artificial intelligence.

"Uniting talented professionals from across the globe provides a unique opportunity for innovation, creativity, and development in diverse areas of expertise," says Devin Dunn, head of the Accelerator for Healthtech at TMCi, in the release. "Our tailored program maximizes participants' experiences while determining the best match between these companies and Texas Medical Center’s network."

The cohort was selected following a November bootcamp that introduced potential startup members to the TMC and the Houston health care community.

The following companies will join the TMC this month:

  • Based in Roseville, Minneapolis, Bloom Standard is deploying the first self-driving pediatric ultrasound to earlier diagnose heart and lung conditions in primary care, remote and under-resourced settings.
  • San Francisco-based Ejenta automates remote monitoring and care using AI technology exclusively licensed from NASA. “Intelligent agents” learn from connected devices, claims and EMR data to monitor patients, predict health and to provide automated support for patients and automated workflow for clinicians.
  • Kintsugi, based in Berkley, California, is on a mission to see mental health more clearly by developing novel voice biomarker infrastructure to detect signs of depression and anxiety from short clips of free-form speech.
  • San Francisco-based Lana Health is modernizing patient experiences, across the care continuum with an end-to-end, scalable platform, enabling frictionless care transitions, high patient satisfaction, and better clinical outcomes.
  • Liberate Medical, from Crestwood, Kentucky, improves outcomes for mechanically ventilated patients using its breakthrough, non-invasive, respiratory muscle-protective, neurostimulation device, VentFree.
  • Limbix, headquartered in Palo Alto, has a mission to improve mental health with accessible technology.
  • Nua Surgical, from Galway, Ireland, Nua Surgical is an award-winning Irish start-up dedicated to innovating in women’s health.
  • Houston-based Prana Thoracic is developing solutions for the detection and intervention of early-stage lung cancer.

Accelerator for Cancer Therapeutics

The TMC has announced the 21 researchers and companies tapped to join the 2023 Accelerator for Cancer Therapeutics.

The nine-month program, funded by the Cancer Prevention and Research Institute of Texas in partnership with the Gulf Coast Consortia and the University of Texas Medical Branch, supports investigators and early-stage biotechnology companies with innovative solutions in cancer therapeutics. Participants will be mentored by a group of scientific, business, and innovation leaders to ultimately be positioned to apply for grants and pitch to investors and corporate partners to further the development of their innovative cancer solutions.

“For this third cohort, we focused on a strategic and extensive recruitment process, including the evaluation of 1,679 cancer research projects. From 56 applications, we selected 21 participants that will gain access to valuable resources, integrated training and mentorship to prepare for clinical trials,” says Ahmed AlRawi, program manager of Accelerator for Cancer Therapeutics, in the release. “Our 2023 cohort represents our most diverse cohort to date, including eight companies led by women entrepreneurs. We are excited to continue the momentum and build off the successes of our previous years.”

Forty-five participants have gone through the accelerator program since its launch in 2021, and collectively, the entrepreneurs have raised more than $90 million in funding and three projects are in the clinic.

The 2023 cohort participants are focused on a wide range of therapeutic assets, including small molecule, antibody, peptide/protein, cell therapy, and other. The 2023 cohort kicks off their nine-month program in January.

The participants include:

  1. Dr. Amit K. Tripathi – UNT-Health Science Center
  2. Dr. Darshan Gandhi (ImproveBio, LLC)
  3. Dr. Frank McKeon (Tract Pharmaceutical) – University of Houston
  4. Dr. Hemanta Baruah (Aakha Biologics)
  5. Dr. Joshua Gruber – UT-Southwestern
  6. Dr. Kyoji Tsuchikama – UT Health Science Center-Houston
  7. Dr. Maralice Conacci Sorrell – UT-Southwestern
  8. Dr. Michael Buszczak – UT-Southwestern
  9. Dr. Nadezhda (Nadia) German -Texas Tech-Lubbock
  10. Dr. Parsa Modareszadeh (HemePro Therapeutics) – UT-Dallas
  11. Dr. Robert Kruse (HydroGene Therapeutics)
  12. Dr. Xiang Zhang – Baylor College of Medicine
  13. Dr. Youngwook Won (Singular Immune, Inc.)
  14. Dr. Zhi-Ping Liu (Raphael Pharmaceutical LLC) – UT-Southwestern
  15. Dr. Jonathan Arambula (InnovoTEX Inc.)
  16. Dr. Isaac Chan – UT-Southwestern
  17. Dr. Olga Granaturova (Ruptakine Inc.) – UT Health Science Center-Houston
  18. Dr. Jim Song (Tranquility Biodesign) – Texas A&M-College Station
  19. Dr. Rosa Selenia Guerra-Resendez (Quetzal Bio, LLC) – Rice University
  20. Dr. Cassian Yee (Mongoose Bio, LLC) – UT-MD Anderson Cancer Center
  21. Dr. Manjeet Rao (Niragen, Inc.) – UT Health Science Center-San Antonio


Trending News